Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio Growth (5y) (2015 - 2025)
Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.69% |
| Sep 30, 2025 | 67.02% |
| Jun 30, 2025 | 77.52% |
| Mar 31, 2025 | 51.36% |
| Dec 31, 2024 | 75.42% |
| Sep 30, 2024 | 33.04% |
| Jun 30, 2024 | 42.90% |
| Mar 31, 2024 | 42.01% |
| Dec 31, 2023 | -139.93% |
| Sep 30, 2023 | 50.48% |
| Jun 30, 2023 | 20.39% |
| Dec 31, 2022 | -161.34% |
| Dec 31, 2020 | 47.01% |
| Sep 30, 2020 | -113.67% |
| Jun 30, 2020 | -69.98% |
| Mar 31, 2020 | -73.63% |
| Dec 31, 2019 | 57.55% |
| Sep 30, 2019 | 30.95% |
| Jun 30, 2019 | 13.92% |
| Mar 31, 2019 | -73.72% |